市場調査レポート
商品コード
1452818
遺伝子毒性検査の世界市場規模、シェア、成長分析:製品別、用途別 - 産業予測(2024~2031年)Global Genetic Toxicology Testing Market Size, Share, Growth Analysis, By Product(Reagents & Consumables, Assays), By Application(Pharmaceutical & Biotechnology, Food Industry) - Industry Forecast 2024-2031 |
遺伝子毒性検査の世界市場規模、シェア、成長分析:製品別、用途別 - 産業予測(2024~2031年) |
出版日: 2024年03月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
世界の遺伝子毒性検査の市場規模は、2022年に13億1,000万米ドルとなり、2023年の14億8,000万米ドルから、2031年までには38億4,000万米ドルに成長し、予測期間(2024~2031年)のCAGRは12.70%で成長する見通しです。
遺伝子毒性検査は、製薬、バイオテクノロジー、化学産業において重要な役割を果たしており、新薬、化学物質、消費者製品の安全性評価において基本的な要素となっています。この段階は、人の健康と環境の両方に対する潜在的リスクを徹底的に評価することを保証するものです。市場の重要性は、規制当局の監視の強化、検査手法の進歩、公衆衛生と安全性への関心の高まりにより、上昇傾向にあります。顕著な成長を促す要因としては、製薬・化学分野における研究開発活動の拡大、世界の保健衛生規制の厳格化、遺伝毒性物質への曝露による長期的影響の可能性に対する意識の高まりなどが挙げられます。従来の検査が不可欠であることに変わりはありませんが、in vitro小核アッセイ、in silicoモデリング、ハイスループットスクリーニング法などの革新的な技術がそれらを補完し、より迅速で正確、かつ費用対効果の高い検査を可能にしています。さらに、動物の使用を最小限に抑えるための代替検査法へのシフトは、倫理的配慮と規制要件に合致しており、非動物検査モデルの採用を促進しています。遺伝子毒性検査を専門とする開発業務受託機関など、市場の主要企業は、多様な検査サービスを提供することで、市場のダイナミックな状況に貢献しています。
Global Genetic Toxicology Testing Market size was valued at USD 1.31 billion in 2022 and is poised to grow from USD 1.48 billion in 2023 to USD 3.84 billion by 2031, growing at a CAGR of 12.70% during the forecast period (2024-2031).
Genetic toxicology testing plays a crucial role in the pharmaceutical, biotechnology, and chemical industries, serving as a fundamental component in the safety assessment of new drugs, chemicals, and consumer products. This phase ensures a thorough evaluation of potential risks to both human health and the environment. The market's significance is on the rise due to heightened regulatory scrutiny, advancements in testing methodologies, and an increased focus on public health and safety. Factors driving its notable growth include expanding research and development activities in pharmaceutical and chemical sectors, stringent global health regulations, and a growing awareness of the potential long-term impacts of exposure to genotoxic substances. While traditional tests remain essential, innovative techniques such as in vitro micronucleus assays, in silico modeling, and high-throughput screening methods are complementing them, facilitating faster, more accurate, and cost-effective testing. Additionally, the shift towards alternative testing methods to minimize animal usage aligns with ethical considerations and regulatory requirements, fostering the adoption of non-animal testing models. Key players in the market, including contract research organizations specializing in genetic toxicology testing, contribute to its dynamic landscape by offering a diverse range of testing services.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genetic Toxicology Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Genetic Toxicology Testing Market Segmental Analysis
The global genetic toxicology testing market is segmented on the basis of Type, Product, Application and region. By Type, the market is segmented into In Vitro, In Vivo. By Product, the market is segmented into Reagents & Consumables, Assays, Services. By Application, the market is segmented into Pharmaceutical & Biotechnology, Food Industry, Cosmetics Industry, Other. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Genetic Toxicology Testing Market
The increasing recognition among individuals and healthcare professionals regarding the significance of genetic health and its consequences serves as a major catalyst. Genetic toxicology testing plays a crucial role in pinpointing potential hazards linked to exposure to diverse environmental elements like chemicals, medications, and pollutants. This, in turn, contributes to personalized healthcare and facilitates the implementation of preventive measures.
Restraints in the Global Genetic Toxicology Testing Market
Genetic toxicology testing delves into scrutinizing an individual's genetic data, giving rise to ethical considerations regarding privacy, consent, and the potential for data misuse. The meticulous management of genetic information, encompassing its collection, storage, and utilization, necessitates adherence to stringent privacy regulations. This cautious approach may pose a challenge to the broad acceptance and integration of genetic testing practices.
Market Trends of the Global Genetic Toxicology Testing Market
The market is undergoing a notable transition towards in vitro genetic toxicology testing techniques, supplanting traditional animal-based methods with cell-based assays. This shift is fueled by the benefits these assays provide, including diminished ethical concerns, quicker results, cost-effectiveness, and enhanced relevance to human biology. In vitro approaches like the Ames test, micronucleus assay, and Comet assay are increasingly popular for their capacity to furnish precise data on the genotoxicity and mutagenicity potential of substances. Regulatory bodies are actively endorsing the adoption of in vitro methods, amplifying their incorporation into the industry.